307 related articles for article (PubMed ID: 25684957)
41. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
[TBL] [Abstract][Full Text] [Related]
42. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.
Boyce PM; Talley NJ; Balaam B; Koloski NA; Truman G
Am J Gastroenterol; 2003 Oct; 98(10):2209-18. PubMed ID: 14572570
[TBL] [Abstract][Full Text] [Related]
43. Multicenter study of gastroenterologists' ability to identify anxiety and depression in a new patient encounter and its impact on diagnosis.
Keefer L; Sayuk G; Bratten J; Rahimi R; Jones MP
J Clin Gastroenterol; 2008 Jul; 42(6):667-71. PubMed ID: 18496395
[TBL] [Abstract][Full Text] [Related]
44. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment.
Drossman D; Morris CB; Hu Y; Toner BB; Diamant N; Whitehead WE; Dalton CB; Leserman J; Patrick DL; Bangdiwala SI
Am J Gastroenterol; 2007 Jul; 102(7):1442-53. PubMed ID: 17509027
[TBL] [Abstract][Full Text] [Related]
45. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
[TBL] [Abstract][Full Text] [Related]
46. Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: a randomized effectiveness trial.
Weisz JR; Chorpita BF; Palinkas LA; Schoenwald SK; Miranda J; Bearman SK; Daleiden EL; Ugueto AM; Ho A; Martin J; Gray J; Alleyne A; Langer DA; Southam-Gerow MA; Gibbons RD;
Arch Gen Psychiatry; 2012 Mar; 69(3):274-82. PubMed ID: 22065252
[TBL] [Abstract][Full Text] [Related]
47. Defining Optimal Care for Functional Gut Disorders - Multi-Disciplinary Versus Standard Care: A Randomized Controlled Trial Protocol.
Basnayake C; Kamm MA; Salzberg M; Khera A; Liew D; Burrell K; Wilson-O'Brien A; Stanley A; Talley NJ; Thompson AJ
Contemp Clin Trials; 2019 Sep; 84():105828. PubMed ID: 31437539
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of clinical outcomes in an interdisciplinary abdominal pain clinic: A retrospective, exploratory review.
Deacy AD; Friesen CA; Staggs VS; Schurman JV
World J Gastroenterol; 2019 Jun; 25(24):3079-3090. PubMed ID: 31293343
[TBL] [Abstract][Full Text] [Related]
49. Why do subjects with irritable bowel syndrome seek health care for their symptoms?
Ringström G; Abrahamsson H; Strid H; Simrén M
Scand J Gastroenterol; 2007 Oct; 42(10):1194-203. PubMed ID: 17852851
[TBL] [Abstract][Full Text] [Related]
50. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
[TBL] [Abstract][Full Text] [Related]
51. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.
Gonsalkorale WM; Houghton LA; Whorwell PJ
Am J Gastroenterol; 2002 Apr; 97(4):954-61. PubMed ID: 12003432
[TBL] [Abstract][Full Text] [Related]
52. Review article: epidemiology and quality of life in functional gastrointestinal disorders.
Chang L
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():31-9. PubMed ID: 15521853
[TBL] [Abstract][Full Text] [Related]
53. High somatic symptom burdens and functional gastrointestinal disorders.
Sayuk GS; Elwing JE; Lustman PJ; Clouse RE
Clin Gastroenterol Hepatol; 2007 May; 5(5):556-62. PubMed ID: 17258513
[TBL] [Abstract][Full Text] [Related]
54. [Functional gastrointestinal disorders].
Moser G
Wien Med Wochenschr; 2006 Aug; 156(15-16):435-40. PubMed ID: 17041768
[TBL] [Abstract][Full Text] [Related]
55. Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina.
Palsson OS; van Tilburg M
Am J Clin Hypn; 2015 Jul; 58(1):5-21. PubMed ID: 26046714
[TBL] [Abstract][Full Text] [Related]
56. [Depressive and anxiety symptoms, coping strategies in patients with irritable bowel syndrome and inflammatory bowel disease].
Kovács Z; Kovács F
Psychiatr Hung; 2007; 22(3):212-21. PubMed ID: 18167418
[TBL] [Abstract][Full Text] [Related]
57. Traumatized refugees: morbidity, treatment and predictors of outcome.
Buhmann CB
Dan Med J; 2014 Aug; 61(8):B4871. PubMed ID: 25162447
[TBL] [Abstract][Full Text] [Related]
58. Effect of digestive health care services integration on resource use and outcomes in patients with digestive disorders.
Arseneau KO; Yeaton P; Kahaleh M; Cominelli F
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):145-51. PubMed ID: 15017507
[TBL] [Abstract][Full Text] [Related]
59. Patients with irritable bowel syndrome and constipation are more depressed than patients with functional constipation.
Bouchoucha M; Hejnar M; Devroede G; Boubaya M; Bon C; Benamouzig R
Dig Liver Dis; 2014 Mar; 46(3):213-8. PubMed ID: 24252578
[TBL] [Abstract][Full Text] [Related]
60. Hypnotherapy for functional gastrointestinal disorders.
Drug Ther Bull; 2005 Jun; 43(6):45-8. PubMed ID: 15966557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
